TipRanks
pc:sense

Senseera

Professor Racah street Jerusalem, IL
https://www.senseerahealth.com/
Senseera is a liquid biopsy company specializing in chromatin epigenomics. Their GEM BIOMARKERS™ platform, utilizing cfChIP-seq technology, enables the decoding of cell-specific gene expression and cell states from a simple blood draw. This innovative approach provides detailed molecular insights for diagnosing and monitoring diseases, offering the precision of biopsy-level insights with the convenience of a non-invasive test.

Leadership & Board

Current Number of Employees18
Current LinkedIn Followers1,626

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$7M
Total Amount Raised$7M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$7M
Latest Funding Amount$7M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

Senseera had 18 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Senseera had 1,626 followers as of September 28, 2026. The number of followers increased by 2 (0.12%) week-over-week.
1,626Latest Followers Count
2(0.12%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2025
Seed Round
$7.10M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Senseera, helping you discover and navigate related company profiles.

Related News and Analysis